Solos Endoscopy, Inc. announced that the company has commenced negotiations with a Canadian distributor to sell its endoscopic instruments including the MammoView(R) devices in Canada. Canada's medical device market tops $6 Billion in annual revenues, with 80% of the market concentrated in Ontario and Quebec.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.305 USD | -12.86% |
|
-.--% | -40.20% |
04-02 | CYduct Diagnostics, Inc. Announces Positive Study Results for Biomarker Combinations in the Assessment of Breast Cancer | CI |
2021 | CYduct Diagnostics, Inc. announced a financing transaction | CI |
- Stock Market
- Equities
- CYDX Stock
- News CYduct Diagnostics, Inc.
- Solos Endoscopy to Begin Distribution of its Endoscopic Instruments in Canada